Virion half-life in chronic hepatitis B infection is strongly correlated with levels of Viremia

Hepatology

Volumn 48, Issue 4, 2008, Pages 1079-1086

  Dandri, Maura ^a   Murray, John M ^b   Lutgehetmann, Marc ^a   Volz, Tassilo ^a   Lohse, Ansgar W ^a   Petersen, Joerg ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CHRONIC HEPATITIS B; HALF LIFE TIME; HEPATITIS B; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MICROBIAL ACTIVITY; MICROBIAL KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA; VIRION; VIRUS INHIBITION; VIRUS LOAD; ADULT; ANIMAL; BIOLOGICAL MODEL; BIOPSY; BLOOD; CHIMERA; FEMALE; GENE DOSAGE; GENETICS; HEPATITIS B VIRUS; LIVER; LIVER CELL; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THEORETICAL MODEL; TRANSGENIC MOUSE; VIROLOGY;

ADULT; ANIMALS; BIOPSY; CHIMERA; DNA, VIRAL; FEMALE; GENE DOSAGE; HALF-LIFE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; LIVER; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, THEORETICAL; URINARY PLASMINOGEN ACTIVATOR; VIRAL LOAD; VIREMIA; VIRION;

EID: 54449096510     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22469     Document Type: Article

References (25)

1. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
2. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006;101:1797-1803.
3. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: Natural history and treatment. Semin Liver Dis 2006; 26:130-141.
4. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
5. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 1999;354:1782-1785.
6. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998;282:103-107.
7. Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, et al. Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed. HEPATOLOGY 2001;34:1012-1020.
8. Murray JM, Purcell RH, Wieland SF. The half-life of hepatitis B virions. HEPATOLOGY 2006;44:1117-1121.
9. Murray JM, Wieland SF, Purcell RH, Chisari FV. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci U S A 2005;102: 17780-17785.
10. Gerlich WH, Wend U, Glebe D. Quantitative assay of hepatitis B surface antigen in serum of plasma using Laurell electrophoresis. Methods Mol Med 2004;95:57-63.
11. Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. HEPATOLOGY 2006;44:675-684.
12. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-1758.
13. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 2007;133: 843-852.
14. Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991;66:245-256.
15. Dandri M, Burda MR, Zuckerman DM, Wursthorn K, Matschl U, Pollok JM, et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 2005;42:54-60.
16. Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 2008;26:335-341.
17. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403-415.
18. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886-1900.
19. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. HEPATOLOGY 2004;40: 738-746.
20. Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. HEPATOLOGY 2007;45:102-110.
21. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 2003;69:313-323.
22. Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 2003;39:595-605.
23. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007;85:16-23.
24. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007;81:4215-4225.
25. Ciupe SM, Ribeiro RM, Nelson PW, Perelson AS. Modeling the mechanisms of acute hepatitis B virus infection. J Theor Biol 2007;247:23-35.